Indian Journal of Medical and Paediatric Oncology

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 34  |  Issue : 3  |  Page : 186--188

A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh


Pankaj Malhotra, Neelam Varma, Subhash Varma 
 Department of Internal Medicine and Hematology, Post Graduate Institute, Chandigarh, India

Correspondence Address:
Pankaj Malhotra
Department of Internal Medicine, Post Graduate Institute of Medical Education & Research, Chandigarh
India

Post Graduate Institute (PGI) Chandigarh is a premier institute of North India. There are approximately 70,000 admissions per year. The adult clinical hematology department sees more than 2000 new patients per year. A preliminary analysis of 299 chronic myeloid leukemia patients registered from January 2001 until December 2007 was done. Out of these, 256 (86%) patients were in chronic phase (CP). The median age at presentation was 40 years. At 6 months of follow-up 95% of patients who were started on Imatinib mesylate based therapy remained in CP. Partial cytogenetic remission was seen in 69% of patients while complete cytogenetic response was seen in only 20% of patients at 6 months on Imatinib mesylate.


How to cite this article:
Malhotra P, Varma N, Varma S. A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh.Indian J Med Paediatr Oncol 2013;34:186-188


How to cite this URL:
Malhotra P, Varma N, Varma S. A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh. Indian J Med Paediatr Oncol [serial online] 2013 [cited 2019 Oct 16 ];34:186-188
Available from: http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=186;epage=188;aulast=Malhotra;type=0